In our study, our results indicated that Tim-3 on the surface of γδ T cells in the peripheral blood of CAD patients is significantly higher than that of healthy individuals, suggesting that the Tim-3+γδ T cells might be involved in the formation of atherosclerosis, and may be an alternative therapeutic target. This evidence concerns the gene HAVCR2 and atherosclerosis.